Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Anand C, Patel"'
Autor:
Daniel J. Wallace, Thomas Dörner, David S. Pisetsky, Jorge Sanchez‐Guerrero, Anand C. Patel, Dana Parsons‐Rich, Claire Le Bolay, Elise E. Drouin, Amy H. Kao, Hans Guehring, Maria Dall'Era
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 1, Pp 38-48 (2023)
Objective Evobrutinib is a highly selective, orally administered Bruton's tyrosine kinase (BTK) inhibitor. The objective of this phase II, multicenter, randomized, double‐blind, placebo‐controlled trial was to evaluate the efficacy and safety of
Externí odkaz:
https://doaj.org/article/fbfb7923863e4170999f2062f9b263dc
Autor:
Anand C Patel, Vipul D Yagnik
Publikováno v:
Formosan Journal of Surgery, Vol 52, Iss 3, Pp 76-83 (2019)
Background: Pancreatic fistula (PF) remains the most common and challenging complication following pancreaticoduodenectomy (PD), with an incidence of 2%–28%. The primary objective of this study was to assess the correlation of fatty infiltration an
Externí odkaz:
https://doaj.org/article/2dc7e74c1dac4cec9d0567929942f8f7
Autor:
Daniel J. Wallace, Thomas Dörner, David S. Pisetsky, Jorge Sanchez‐Guerrero, Anand C. Patel, Dana Parsons‐Rich, Claire Le Bolay, Elise E. Drouin, Amy H. Kao, Hans Guehring, Maria Dall'Era
Publikováno v:
ACR Open Rheumatology. 5:38-48
Autor:
Daniel J, Wallace, Thomas, Dörner, David S, Pisetsky, Jorge, Sanchez-Guerrero, Anand C, Patel, Dana, Parsons-Rich, Claire, Le Bolay, Elise E, Drouin, Amy H, Kao, Hans, Guehring, Maria, Dall'Era
Publikováno v:
ACR open rheumatologyREFERENCES.
Evobrutinib is a highly selective, orally administered Bruton's tyrosine kinase (BTK) inhibitor. The objective of this phase II, multicenter, randomized, double-blind, placebo-controlled trial was to evaluate the efficacy and safety of evobrutinib in
Autor:
Vipul D Yagnik, Anand C Patel
Publikováno v:
Formosan Journal of Surgery, Vol 52, Iss 3, Pp 76-83 (2019)
Background: Pancreatic fistula (PF) remains the most common and challenging complication following pancreaticoduodenectomy (PD), with an incidence of 2%–28%. The primary objective of this study was to assess the correlation of fatty infiltration an
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36594 (2012)
Most of current strategies for antiviral therapeutics target the virus specifically and directly, but an alternative approach to drug discovery might be to enhance the immune response to a broad range of viruses. Based on clinical observation in huma
Externí odkaz:
https://doaj.org/article/21f319dea4ed48dd93fa30110fdf52f1
Publikováno v:
Abstracts.
Background Brutons tyrosine kinase (BTK) regulates B-cell receptor signaling and is a rational target for B-cell driven pathologies, including SLE. Evobrutinib (M2951) is a highly specific, oral inhibitor of BTK that demonstrated efficacy in preclini
Autor:
Anand C. Patel, Kangyun Wu, Marco Colonna, Susan Gilfilan, Michael J. Holtzman, Xiaohua Jin, Jennifer Alexander-Brett, Daniel L. Kober, Derek E. Byers, Marina Cella, Eugene Agapov, Tom J. Brett
Publikováno v:
The Journal of Experimental Medicine
Wu et al. use a mouse model to show that active respiratory viral infection triggers TREM-2 expression on the macrophage cell surface and thereby prevents macrophage apoptosis during the acute illness. In addition, long after viral clearance, IL-13 a
Autor:
Jennifer-Alexander Brett, Kangyun Wu, Xiaohua Jin, Anand C. Patel, Eugene Agapov, Derek E. Byers, Michael J. Holtzman
Publikováno v:
Annals of the American Thoracic Society. 11:S287-S291
Respiratory infection is a common feature of the major human airway diseases, such as asthma and chronic obstructive pulmonary disease, but the precise link between acute infection and chronic lung disease is still undefined. In a mouse model of this
Autor:
E. Premkumar Reddy, Tao Huang, Anand C. Patel, Nicholas Yozamp, Steven L. Brody, Derek E. Byers, Jie Hong Pan, Jian Xu, Michael J. Holtzman, Richard A. Pierce, Tracy L. Adair-Kirk
Publikováno v:
Stem Cells. 32:3245-3256
The epithelium of the pulmonary airway is specially differentiated to provide defense against environmental insults, but also subject to dysregulated differentiation that results in lung disease. The current paradigm for airway epithelial differentia